MoshaDong, Takeda two major pharmaceutical companies in South Korea met with the various trade unions attacked!

Medicine network August 7 - The basic duty of the trade union is to safeguard the legitimate rights and interests of workers, such as our Trade Union Law provides: "Trade union organizations on behalf of the interests of workers, in accordance with the law to safeguard the legitimate rights and interests of workers." "
recently in South Korea, Moshadand and Takeda have come under fire from various trade unionsfirst of all Takeda Pharmaceuticals, according to South Korean media reports, Takeda Korea's trade union said that in the process of the merger of Takeda Korea and Shire Korea, Takeda's employees face unfair job and job changessince Takeda's acquisition of Shire, the two South Korean companies have merged, as have their subsidiaries in other countriesMoon Hee-seok, the former chief executive of Shire Korea, took over as chief executive of Takeda Pharmaceuticals Korea after the merger and led a restructuring process that was seen as beneficial only to Shire employeesTakeda Pharmaceuticals Korea Union said that during the restructuring process, the former Takeda employees' jobs and positions of unfair changes, as well as Takeda and Shire employees of different sales incentives, Wutian employees feel discriminated againstunion spokesman cited examples such as the merger, where dozens of Takeda employees left because of overlapping positions, but none of the Shire employees left, adding that one Of the Wutian employee's request for a transfer was not fulfilled and that another shire employee would be able to move to the ideal positionalso, sales incentives are also detrimental to Takeda employees, such as the team responsible for digesting products has 5 Shire employees and 5 Takeda employees, shire employees receive disburseted bonuses are proportional to wages, but Takeda's bonus can only be proportional to performance, in which case, even if the performance of both sides is the same, Shire employees can get a higher bonusTakeda Korea denied the claims, saying that no layoffs were made because of the merger, and that dozens of Takeda employees had left for personal reasons, such as considering personal career development, and that job adjustments were based on business needs and organizational and personal considerationsTakeda Pharmaceuticals Korea Has been negotiating with the company in recent years for the bonus policy of take-field sales and the
standards for pay increases, and the Takeda Pharmaceuticals Korea Union has filed a labor dispute mediation application with the Korean National Labor Relations Commission on the matterwent on to say that the dispute between the Mercado,mohs, the Mercado-South Korean union and the company was over a "self-assurance" program that began last year when South Korean regulators allowed drug companies to keep records of all "financial aid" provided to doctors and pharmacists, so Moshad on South Korea launched the program to check compliance with its medical representativesAccording to South Korean media reports, The small product promotion company of 5 to 25 people will be randomly selected at a rate of 5%, through third-party organizations to monitor, should be equivalent to our domestic small-scale flight inspectionthe project not only monitors the staff of Mersadon, but also records conversations between all doctors and Messadon employees at product promotion slots, which has also angered doctorsafter complaints from employees, the program was solicited for advice in June and July, and new improvements were announced on July 29 However, the Mercadon Korea Union said management's so-called collection proposals were merely a show and that under the current improvement plan, employees still had no choice but to continue with the original monitoring program originally, the so-called improvement program provides two options, to maintain the original monitoring program, to suspend the product promotion, the union believes that the elimination of product promotion will mean that pharmaceutical representatives lost the tools to promote drug , which actually forced pharmaceutical representatives can only choose to continue to maintain the original monitoring program, the company actually did not have the will to improve the situation